(OK-432 Immunotherapy Study Group): A Randomized Controlled Study of OK-432 for Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
doi 10.5981/jjhnc1974.15.2_183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society for Head and Neck Cancer

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy